References:

1. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER).
   CBER clinical review of studies submitted in support of licensure of ProQuad. https:// www.fda.gov/media/165978/download. Accessed July 2026.
2. ProQuad Summary of Product Characteristics.

AE-QDX-00012 | Exp: 25 July 2028